Fellow UK drugs firm Glaxosmithkline, meanwhile, paid £130million for a 10 per cent stake in German vaccine maker Curevac, another key player in the race to find a coronavirus vaccine.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: